Dotmatics (FKA Insightful Science GraphPad)

Acquired

Dotmatics (FKA Insightful Science GraphPad) is a biotech company in San Diego, United States, founded in 2005. It has raised $7.5M across 2 rounds, most recently a $3.8M Seed in March 2021.

Connect science, data, and decision-making

Employees
501–1000
Founded
2005
Business Model
B2B
Total Funding
$7.5M
Last Round
$3.8M SeedMar 2021
Rounds
2
Acquired by
SiemensApr 2025 · $5.1B

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Dotmatics is a scientific R&D software platform used by over 2 million scientists across 10,000+ organizations globally. Founded in 2005, the company offers an integrated suite of tools spanning biology, chemistry, and materials science — including SnapGene, Geneious, GraphPad Prism, and LabArchives — unified under its AI-native Luma platform for multimodal scientific data management, workflow automation, and decision-making. Dotmatics serves leading pharmaceutical companies, biotechs, chemical manufacturers, and academic institutions. The company was acquired by Siemens in a $5.1 billion deal to strengthen Siemens' position in AI-powered life sciences R&D software.

Summary

It lists 501–1000 employees. It has raised $7.5M in total across 2 rounds, most recently a $3.8M Seed round in Mar 2021. Investors include Siemens AG, Insight Partners and Scottish Equity Partners.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionApr 2025

Sign up to see all 3 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dotmatics (FKA Insightful Science GraphPad) on Indexed.vc
<a href="https://indexed.vc/companies/dotmatics-fka-insightful-science-graphpad"><img src="https://indexed.vc/api/badge/company/dotmatics-fka-insightful-science-graphpad" alt="Dotmatics (FKA Insightful Science GraphPad) on Indexed.vc" width="260" height="76" /></a>